#WHO22 - Twitter Hashtag

over 1 year ago

👏Very nice algorithm #AML #WHO22 #ICC2022 Excellent work👌 Start from left upper then follow the arrow ➡️

over 3 years ago

How I classify #AML in 2023 😱 WHO & ICC 👉diagnosis (AML entities) ELN 👉 prognosis (fav vs. int/adverse) #cytology + #mutations + #cytogenetics 🔬🧬

NicolasDuployez's tweet photo. How I classify #AML in 2023 😱
WHO & ICC 👉diagnosis (AML entities)
ELN 👉 prognosis (fav vs. int/adverse)
#cytology + #mutations + #cytogenetics 🔬🧬 https://t.co/mrviobpOkU

9

109

49

42

9K

0

8

4

5

716

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

over 2 years ago

Superstar @LucaLanino presented on a large international collaboration of @ic_MDS @genomed4all @MoffittNews datasets of 7000 patients with AI & consensus process to harmonize #WHO22 & #ICC22 classifications of #MDSsm into ONE system (& answered questions masterfully) @YaleCancer

Dr_AmerZeidan's tweet photo. Superstar @LucaLanino presented on a large international collaboration of @ic_MDS @genomed4all @MoffittNews datasets of 7000 patients with AI & consensus process to harmonize #WHO22 & #ICC22 classifications of #MDSsm into ONE system (& answered questions masterfully) @YaleCancer https://t.co/uE7nsHLX0d

0

23

12

4

3K

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

almost 3 years ago

@MDAndersonNews In #ZeidanMDSsm list for #ASH2023 top 10 #MDSsm abstracts, the 6th abstract comes from the @ic_MDS focused on evidence-based harmonization of the #WHO22 and #ICC22 classifications using international dataset of more than 7000 patients https://t.co/vbNMuCWaja

Dr_AmerZeidan's tweet photo. @MDAndersonNews In #ZeidanMDSsm list for #ASH2023 top 10 #MDSsm abstracts, the 6th abstract comes from the @ic_MDS focused on evidence-based harmonization of the #WHO22 and #ICC22 classifications using international dataset of more than 7000 patients https://t.co/vbNMuCWaja https://t.co/4HRthBRbp5

1

8

2

1

2K

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

about 3 years ago

Very nice analysis questioning the new category of MDS/AML by #ICC22 & supporting decision by #WHO22 to keep as IB2. Risk assessment according to #IPSSM is superior to #AMLsm #ELN22 risk classification in MDS/AML overlap patients defined by ICC | Leukemia https://t.co/C40MPdQLWL

1

55

16

10

8K

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

about 3 years ago

On behalf of an international panel, we issued a call-for-action to harmonize/unify #WHO22 & #ICC22 classifications for #AMLsm warning about important negative consequences to patient care, trials, drug approvals, & epidemiological research with status quo https://t.co/SzFqgKLrjV

4

69

23

9

9K

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

about 3 years ago

I am reminded of this famous quote as we continue to actively push towards a harmonization of #WHO22 & #ICC22 #MDSsm & #AMLsm classifications- “Some people want it to happen, some wish it would happen, others make it happen.” Michael Jordan

1

15

1

0

2K

Somedeb Ball

@drsomedeb

about 3 years ago

Those attending #EHA23, do not miss this presentation by @Ramikomrokji tomorrow on our next steps to facilitate a data-driven harmonization between #WHO22 and #ICC22 for #MDSsm Glad to be part of this fantastic collaboration!! @genomed4all @LucaLanino @Dr_AmerZeidan @ic_MDS

drsomedeb's tweet photo. Those attending #EHA23, do not miss this presentation by @Ramikomrokji tomorrow on our next steps to facilitate a data-driven harmonization between #WHO22 and #ICC22 for #MDSsm Glad to be part of this fantastic collaboration!! @genomed4all @LucaLanino @Dr_AmerZeidan @ic_MDS https://t.co/QFqOT6DmC7

0

14

2

0

2K

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

over 3 years ago

Fantastic debate between @JoeKhouryMD & @sanamloghavi on #WHO22 & #ICC22 merits. I can tell you my conclusion: we need one unified system :)

Dr_AmerZeidan's tweet photo. Fantastic debate between @JoeKhouryMD & @sanamloghavi on #WHO22 & #ICC22 merits. I can tell you my conclusion: we need one unified system :) https://t.co/NfLSmM4cTp

0

35

2

1

6K

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

over 3 years ago

The best thing about our #MDSsm academic community is how collaborative it is & easy to work with. An outstanding group of @MDS_IC members (more than screenshot can fit) working very hard on a framework for evidence-based harmonization of #WHO22 & #ICC22 classification systems!

Dr_AmerZeidan's tweet photo. The best thing about our #MDSsm academic community is how collaborative it is & easy to work with. An outstanding group of @MDS_IC members (more than screenshot can fit) working very hard on a framework for evidence-based harmonization of #WHO22 & #ICC22 classification systems! https://t.co/jXRSrVYGur

2

42

9

2

9K

Moffitt Hematology/Oncology Fellowship @MoffittHemOnc

over 3 years ago · New Orleans

Poster #3099: Hypoplastic MDS is a new #WHO22 category of #MDSsm. See outcome of these patients in cool work by @ZakerSchwabkey on @MoffittNews database at #ASH22 @ASH_hematology @Ramikomrokji @drsomedeb

MoffittHemOnc's tweet photo. Poster #3099: Hypoplastic MDS is a new #WHO22 category of #MDSsm. See outcome of these patients in cool work by @ZakerSchwabkey on @MoffittNews database at #ASH22 @ASH_hematology @Ramikomrokji @drsomedeb https://t.co/zx1SVTAviX

0

10

4

0

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

over 3 years ago

#ASH22 people make sure to go to this talk by rising star dr @drsomedeb under mentorship of dr @Ramikomrokji on behalf of International Consortium of MDS @MDS_IC as the first data-driven comparison of #WHO22 vs #ICC22 classifications for MDS with suggestions to harmonize/improve

Somedeb Ball

@drsomedeb

over 3 years ago

If you treat #MDSsm & want to learn about classes/ subgroups that matter most in #WHO and #ICC 2022, stop by our presentation on analysis of @MoffittNews database Sunday AM #ASH22 Excited to represent @MDS_IC @ASH_hematology @Ramikomrokji @Dr_AmerZeidan @sanamloghavi @ZhuoerXie

drsomedeb's tweet photo. If you treat #MDSsm & want to learn about classes/ subgroups that matter most in #WHO and #ICC 2022, stop by our presentation on analysis of @MoffittNews database Sunday AM #ASH22 Excited to represent @MDS_IC @ASH_hematology @Ramikomrokji @Dr_AmerZeidan @sanamloghavi @ZhuoerXie https://t.co/kIP1DtLNkw

2

39

7

0

2

22

8

1

0

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

almost 4 years ago

Our call for action on behalf of many experts of the international consortium for MDS @MDS_IC to unify the #WHO22 #ICC22 classification schemas in #MDSsm/#MPNsm overlap neoplasms including #CMMLsm based on deliberations at #iwMDS & led by the 🔝 expert @MrinalPatnaik @VJHemOnc

Mrinal Patnaik @MrinalPatnaik

almost 4 years ago · Minnesota

Highlighting differences and recommendations between #ICC and #WHO criteria for #MDSMPNoverlap neoplasms @md_padron @Dr_AmerZeidan @sanamloghavi @ZhuoerXie @DavidSteensma @MikkaelSekeres @TaylorJ_MD https://t.co/NI6cZZbNoH

1

21

6

2

0

1

19

5

2

0

Aref Al-Kali

@AlkaliDr

about 4 years ago

So the new name for Myelodysplastic syndromes is Myelodysplastic neoplasms. However the abbreviation stayed as “MDS”. What! #WHO22 #MDS #Not_MDN

AlkaliDr's tweet photo. So the new name for Myelodysplastic syndromes is Myelodysplastic neoplasms. However the abbreviation stayed as “MDS”. What!

#WHO22
#MDS
#Not_MDN https://t.co/aGGjT8HLv2

2

22

3

1

0

Guillermo Sanz @sanz_guille

about 4 years ago · Chiva

WHO is WHO in #WHO22? 🤔Just a matter or egocentrism the simultaneous #WHO & ICC publications? 😓😡

Amer Zeidan عامر زيدان

@Dr_AmerZeidan

about 4 years ago

Today the 2 most confusing questions I am dealing with are: 1) how to reconcile the WHO and ICC myeloid malignancy classifications in my daily practice and 2) why do people tap on watermelon before buying them?

11

69

7

1

0

1

0

Top Tweets for #WHO22

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users